Who Owns QNRX?

Quoin Pharmaceuticals, Ltd. — Institutional Ownership & 13F Holdings

$5.39

-0.07 (-1.19%)

Market Cap

$5.0M

Shares Outstanding

588,166

Institutional Holders

10

Total Inst. Value

$90K

% of Float Held

QoQ Holder Change

+4

Institutional data as of Q1 2025

New Positions

4

Closed Positions

9

Increased

3

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1UBS Group AG$49K219,295
2Apollon Wealth Management, LLC$18K80,025
3RHUMBLINE ADVISERS$10K41,741
4RAYMOND JAMES FINANCIAL INC$6K25,119
5Lido Advisors, LLCNew$5K23,515
6SUSQUEHANNA INTERNATIONAL GROUP, LLPNew$3K11,210
7SBI Securities Co., Ltd.$24108
8Raiffeisen Bank International AG$417
9JPMORGAN CHASE & CONew$0144
10MORGAN STANLEYNew$0456

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold QNRX?

As of Q1 2025, 10 institutional investors report holding QNRX (Quoin Pharmaceuticals, Ltd.) in their 13F filings.

Which hedge fund owns the most QNRX?

The largest institutional holder of QNRX is UBS Group AG with $49K in shares.

Are institutions buying or selling QNRX?

This quarter, 4 institutions opened new positions in QNRX and 9 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.